vs
Side-by-side financial comparison of DYNEX CAPITAL INC (DX) and VIEMED HEALTHCARE, INC. (VMD). Click either name above to swap in a different company.
VIEMED HEALTHCARE, INC. is the larger business by last-quarter revenue ($76.2M vs $43.5M, roughly 1.8× DYNEX CAPITAL INC). On growth, DYNEX CAPITAL INC posted the faster year-over-year revenue change (531.3% vs 25.5%). Over the past eight quarters, DYNEX CAPITAL INC's revenue compounded faster (75.8% CAGR vs 22.7%).
Dynex Capital Inc. is a publicly traded real estate investment trust headquartered in the United States. It specializes in investing in and managing a diversified portfolio of mortgage-backed securities, residential and commercial mortgage loans, and other mortgage-related assets. It delivers consistent returns to shareholders via regular dividends and long-term capital growth.
Viemed Healthcare, Inc. is a medical technology firm specializing in respiratory care solutions. It develops, manufactures and distributes portable ventilators, respiratory therapy devices and related support services, catering to acute care, post-acute care and home care segments across North America, Europe and key Asia-Pacific markets for patients with respiratory conditions.
DX vs VMD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $43.5M | $76.2M |
| Net Profit | — | $5.6M |
| Gross Margin | — | 57.9% |
| Operating Margin | — | 11.0% |
| Net Margin | — | 7.4% |
| Revenue YoY | 531.3% | 25.5% |
| Net Profit YoY | — | 30.7% |
| EPS (diluted) | $1.59 | $0.14 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $43.5M | $76.2M | ||
| Q3 25 | $30.6M | $71.9M | ||
| Q2 25 | $23.1M | $63.1M | ||
| Q1 25 | $17.1M | $59.1M | ||
| Q4 24 | — | $60.7M | ||
| Q3 24 | — | $58.0M | ||
| Q2 24 | — | $55.0M | ||
| Q1 24 | $-3.2M | $50.6M |
| Q4 25 | — | $5.6M | ||
| Q3 25 | $150.4M | $3.5M | ||
| Q2 25 | $-13.6M | $3.2M | ||
| Q1 25 | $-3.1M | $2.6M | ||
| Q4 24 | — | $4.3M | ||
| Q3 24 | — | $3.9M | ||
| Q2 24 | — | $1.5M | ||
| Q1 24 | $40.1M | $1.6M |
| Q4 25 | — | 57.9% | ||
| Q3 25 | — | 57.5% | ||
| Q2 25 | — | 58.3% | ||
| Q1 25 | — | 56.3% | ||
| Q4 24 | — | 59.5% | ||
| Q3 24 | — | 59.3% | ||
| Q2 24 | — | 59.8% | ||
| Q1 24 | — | 58.9% |
| Q4 25 | — | 11.0% | ||
| Q3 25 | — | 7.8% | ||
| Q2 25 | — | 8.1% | ||
| Q1 25 | — | 6.5% | ||
| Q4 24 | — | 10.6% | ||
| Q3 24 | — | 9.7% | ||
| Q2 24 | — | 6.6% | ||
| Q1 24 | — | 4.4% |
| Q4 25 | — | 7.4% | ||
| Q3 25 | 491.3% | 4.9% | ||
| Q2 25 | -58.8% | 5.0% | ||
| Q1 25 | -18.0% | 4.4% | ||
| Q4 24 | — | 7.1% | ||
| Q3 24 | — | 6.7% | ||
| Q2 24 | — | 2.7% | ||
| Q1 24 | -1256.8% | 3.2% |
| Q4 25 | $1.59 | $0.14 | ||
| Q3 25 | $1.08 | $0.09 | ||
| Q2 25 | $-0.14 | $0.08 | ||
| Q1 25 | $-0.06 | $0.06 | ||
| Q4 24 | — | $0.10 | ||
| Q3 24 | — | $0.10 | ||
| Q2 24 | — | $0.04 | ||
| Q1 24 | $0.64 | $0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $531.0M | $13.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $2.5B | $141.5M |
| Total Assets | $17.3B | $199.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $531.0M | $13.5M | ||
| Q3 25 | $491.0M | $11.1M | ||
| Q2 25 | $387.5M | $20.0M | ||
| Q1 25 | $327.4M | $10.2M | ||
| Q4 24 | — | $17.5M | ||
| Q3 24 | — | $11.3M | ||
| Q2 24 | — | $8.8M | ||
| Q1 24 | $295.7M | $7.3M |
| Q4 25 | $2.5B | $141.5M | ||
| Q3 25 | $2.0B | $133.6M | ||
| Q2 25 | $1.6B | $139.7M | ||
| Q1 25 | $1.4B | $134.8M | ||
| Q4 24 | — | $131.4M | ||
| Q3 24 | — | $125.0M | ||
| Q2 24 | — | $119.4M | ||
| Q1 24 | $958.5M | $116.3M |
| Q4 25 | $17.3B | $199.2M | ||
| Q3 25 | $14.2B | $202.4M | ||
| Q2 25 | $11.3B | $184.6M | ||
| Q1 25 | $9.0B | $178.1M | ||
| Q4 24 | — | $177.1M | ||
| Q3 24 | — | $169.5M | ||
| Q2 24 | — | $163.9M | ||
| Q1 24 | $6.3B | $154.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $120.8M | $18.4M |
| Free Cash FlowOCF − Capex | — | $9.7M |
| FCF MarginFCF / Revenue | — | 12.7% |
| Capex IntensityCapex / Revenue | — | 11.5% |
| Cash ConversionOCF / Net Profit | — | 3.27× |
| TTM Free Cash FlowTrailing 4 quarters | — | $11.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $120.8M | $18.4M | ||
| Q3 25 | $68.3M | $18.4M | ||
| Q2 25 | $31.9M | $12.3M | ||
| Q1 25 | $6.4M | $2.9M | ||
| Q4 24 | — | $15.0M | ||
| Q3 24 | — | $12.7M | ||
| Q2 24 | — | $10.2M | ||
| Q1 24 | $-17.1M | $1.2M |
| Q4 25 | — | $9.7M | ||
| Q3 25 | — | $10.7M | ||
| Q2 25 | — | $4.1M | ||
| Q1 25 | — | $-12.6M | ||
| Q4 24 | — | $3.2M | ||
| Q3 24 | — | $1.7M | ||
| Q2 24 | — | $1.2M | ||
| Q1 24 | — | $-4.8M |
| Q4 25 | — | 12.7% | ||
| Q3 25 | — | 14.9% | ||
| Q2 25 | — | 6.5% | ||
| Q1 25 | — | -21.4% | ||
| Q4 24 | — | 5.2% | ||
| Q3 24 | — | 3.0% | ||
| Q2 24 | — | 2.3% | ||
| Q1 24 | — | -9.5% |
| Q4 25 | — | 11.5% | ||
| Q3 25 | — | 10.6% | ||
| Q2 25 | — | 12.9% | ||
| Q1 25 | — | 26.2% | ||
| Q4 24 | — | 19.5% | ||
| Q3 24 | — | 19.0% | ||
| Q2 24 | — | 16.3% | ||
| Q1 24 | — | 11.9% |
| Q4 25 | — | 3.27× | ||
| Q3 25 | 0.45× | 5.23× | ||
| Q2 25 | — | 3.88× | ||
| Q1 25 | — | 1.09× | ||
| Q4 24 | — | 3.47× | ||
| Q3 24 | — | 3.29× | ||
| Q2 24 | — | 6.94× | ||
| Q1 24 | -0.43× | 0.73× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
